General Information of Drug (ID: DMPWOH9)

Drug Name
DKY709 Drug Info
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Cross-matching ID
PubChem CID
137519326
TTD Drug ID
DMPWOH9

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Zinc finger protein Helios (IKZF2) TTKT5NV IKZF2_HUMAN Degrader [2]

References

1 ClinicalTrials.gov (NCT03891953) Study of Safety and Efficacy of DKY709 Alone or in Combination With PDR001 in Patients With Advanced Solid Tumors.. U.S. National Institutes of Health.
2 Targeted protein degraders crowd into the clinic. Nat Rev Drug Discov. 2021 Apr;20(4):247-250.